BrightSpring Health Services, Inc.

What they do

BrightSpring operates two segments: Pharmacy Solutions, which provides daily medication therapy management to patients in homes, senior living communities, skilled nursing facilities and clinics, and Provider Services, which delivers home health, hospice, rehab therapy, personal care and home-based primary care. The company reports serving over 465,000 patients daily through approximately 10,500 clinical providers and pharmacists. Its stated focus is Senior and Specialty patients, including behavioral populations, in lower-cost home and community settings.

Revenue drivers

• Pharmacy Solutions — The larger segment, at $3,407 million of second quarter 2026 revenue versus $466 million for Provider Services, serving patients in homes, senior living communities, skilled nursing facilities, hospice and clinics. Management frames it as a scaled national infrastructure for daily medication therapy management.
• Provider Services — Smaller but faster-growing, at $466 million in second quarter 2026 revenue, up 30% year over year, covering clinical services (home health, hospice, rehab therapy) plus supportive care for activities of daily living.
• Complex patient population — The company targets high-need, high-cost Senior and Specialty patients, citing a market of over $2.0 trillion and noting that Americans with five or more chronic conditions are over 12% of the population and account for 41% of health care spending.

Recent performance

Second quarter 2026 net revenue was $3,873 million, up 23.0% from $3,148 million a year earlier, with Pharmacy Solutions at $3,407 million (up 22%) and Provider Services at $466 million (up 30%). Gross profit rose 31.5% to $493 million, net income was $87 million versus $9 million, and Adjusted EBITDA rose 44.2% to $206 million. Six-month revenue was $7,487 million, up 24%, with total Company Adjusted EBITDA of $395 million, up 45%. Reported leverage was 2.15x at June 30, 2026, down from 2.27x at March 31, 2026. Results reflect continuing operations after the March 30, 2026 divestiture of the Community Living business.

Strategy

Management describes disciplined operational execution and quality focus in delivering care to complex patients. The company completed the divestiture of its Community Living business on March 30, 2026, and its reported results now pertain to continuing operations. In the second quarter it paid down $300.0 million and modified its First Lien Facility, including interest rate refinancings that it says produced interest savings. It also completed a secondary offering by KKR affiliates and some management members and concurrently repurchased 1,026,465 shares for $60.0 million from the underwriter. Management raised full year 2026 revenue and Adjusted EBITDA guidance.

Risks

• Competitive industry — The company faces intense competition in pharmaceutical distribution and in home health, hospice, rehab therapy, personal care, primary care and behavioral health across each geographic market, and notes that skilled nursing facility owners are entering the facility-based pharmacy market.
• Payor rate exposure — The company identifies changes to Medicare and Medicaid rates or payment methods as a risk, with revenue concentrated in Medicare, Medicaid and commercially-insured populations.
• Referral source dependence — The company cites inability to maintain existing patient referral sources or establish new ones as a risk, and notes many payor contracts are not exclusive and local competitors may build strategic referral relationships.
• Third-party cost containment — Cost containment initiatives of third-party payors are listed as a risk that could pressure the company's rates and volumes.

Outlook

Management increased full year 2026 Revenue and Adjusted EBITDA guidance when reporting second quarter results. It cites significant long-term opportunity across its service lines to address the needs of healthcare stakeholders and expresses commitment to innovation and leadership in the industry. No specific guidance figures were included in the excerpt provided.